These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4399089)

  • 1. Catecholamine depletion and adrenergic neurone blockade: studies with debrisoquine.
    Robertson MI; Abbs ET
    J Neurochem; 1971 Oct; 18(10):1999-2001. PubMed ID: 4399089
    [No Abstract]   [Full Text] [Related]  

  • 2. The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives.
    Abbs ET; Dodd MG
    Br J Pharmacol; 1974 Jun; 51(2):237-47. PubMed ID: 4451743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern views on pharmacology. 8. Antagonists of adrenergic neurone activity.
    Crossland J
    Practitioner; 1971 Aug; 207(238):244-50. PubMed ID: 4105249
    [No Abstract]   [Full Text] [Related]  

  • 4. Salivation in mice as an index of adrenergic activity. 3. Partial temperature-dependence of adrenergic drug effects.
    Maling HM; Koppanyi T
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):344-57. PubMed ID: 4403620
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of amiodarone (L 3428), an alpha and beta receptor antagonist, on overflow of transmitter and uptake of noradrenaline in the cat spleen.
    Bacq ZM; Blakeley AG; Summers RJ
    Biochem Pharmacol; 1974 Dec; 23(24):3501-4. PubMed ID: 4155311
    [No Abstract]   [Full Text] [Related]  

  • 6. Dual site of action of phenoxybenzamine in the cat's spleen; blockade of alpha-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine.
    Thoenen H; Hürlimann A; Haefely W
    Experientia; 1964 May; 20(5):272-3. PubMed ID: 5856313
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between debrisoquine and phenylephrine.
    Aminu J; D'Mello A; Vere DW
    Lancet; 1970 Oct; 2(7679):935-6. PubMed ID: 4097321
    [No Abstract]   [Full Text] [Related]  

  • 8. Amidines as adrenergic neurone blocking agents.
    BOURA AL; COPP FC; GREEN AF
    Nature; 1962 Sep; 195():1213-4. PubMed ID: 13871862
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of beta-haloalkylamines and ephedrine on noradrenaline release from the intact spleen of the cat.
    Kirpekar SM; Wakade AR
    Br J Pharmacol; 1970 Jul; 39(3):533-41. PubMed ID: 4394339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine.
    DAY MD
    Br J Pharmacol Chemother; 1962 Apr; 18(2):421-39. PubMed ID: 13884064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines.
    BOURA AL; GREEN AF
    Br J Pharmacol Chemother; 1962 Aug; 19(1):13-41. PubMed ID: 13871863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adrenergic neurone blockade in the hypotensive action of propranolol.
    Eliash S; Weinstock M
    Br J Pharmacol; 1971 Oct; 43(2):287-94. PubMed ID: 4400571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the adrenergic neurone blocker, beta-TM10, on the depletion of noradrenaline induced by denervation or reserpine.
    Hennemann HM; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 265(4):363-71. PubMed ID: 4392042
    [No Abstract]   [Full Text] [Related]  

  • 14. A possible relationship between depletion of noradrenaline and blockade of adrenergic neurones.
    Abbs ET; Robertson MI
    Br J Pharmacol; 1969 May; 36(1):191P-192P. PubMed ID: 5768102
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of monoamines upon rat uterus contractility after blockade of adrenergic system receptors.
    Urban J; Czekanowski R
    Pol Med J; 1971; 10(1):284-91. PubMed ID: 4396795
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of isolated strips of cat spleen for the assay of alpha-adrenergic blocking compounds.
    BICKERTON RK; ROCKHOLD WT; MICALIZZI ER
    J Pharm Sci; 1962 Sep; 51():837-40. PubMed ID: 13868979
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacology of the adrenergic system. II. Interference of drugs with catecholamine storage in and release from the adrenergic system].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1970 Aug; 114(33):1369-76. PubMed ID: 4393655
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197).
    Privitera PJ; Blickenstaff T; Gaffney TE; Mohammed S
    J Pharmacol Exp Ther; 1971 Mar; 176(3):655-61. PubMed ID: 4398744
    [No Abstract]   [Full Text] [Related]  

  • 19. Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.
    Mylecharane EJ; Raper C
    Br J Pharmacol; 1970 May; 39(1):128-38. PubMed ID: 4392958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of some isoindolines and 1,2,3,4-tetrahydroisoquinolines and their evaluation as alpha-adrenergic and adrenergic neuron blocking agents.
    Casagrande C; Galli A; Ferrini R; Miragoli G
    Farmaco Sci; 1972 Jun; 27(6):445-70. PubMed ID: 4402509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.